Home NMPA Announces Cancellation of Registration Certificates for 11 Medical Devices Including Universal Spinal Posterior Fixation System

NMPA Announces Cancellation of Registration Certificates for 11 Medical Devices Including Universal Spinal Posterior Fixation System

Feb 05, 2026 12:05 CST Updated 12:05
TRAUSON

TRAUSON

According to the Regulations on the Supervision and Administration of Medical Devices, based on the enterprise's application, the National Medical Products Administration hereby cancels the medical device registration certificates for a total of 11 products from the following four companies:
 
I. TRAUSONMedical DeviceTRAUSON Medical Appliance (jiangsu) Co., Ltd.'s 6 products: Universal Posterior Spinal Fixation System, Registration Certificate No.: National Medical Device Registration Approval 20183131872; Universal Posterior Spinal Fixation System, National Medical Device Registration Approval 20153130585; Vertebroplasty System, Registration Certificate No.: National Medical Device Registration Approval 20183041927; Interbody Fusion Cage, Registration Certificate No.: National Medical Device Registration Approval 20173130776; Anterior Cervical Plate System, Registration Certificate No.: National Medical Device Registration Approval 20193130052; Laminoplasty Plate System, Registration Certificate No.: National Medical Device Registration Approval 20213130982.
 
2. Three products of All Medicus Co., Ltd.: Blood Glucose Test Strips (Glucose Dehydrogenase Method), Registration Certificate No.: Instrument Registration Approval 20172406917; Control Solution, Registration Certificate No.: Instrument Registration Approval 20232400560; Blood Glucose Test Meter, Registration Certificate No.: Instrument Registration Approval 20172226843.
 
3. (Co.) Wuchang MedicalHealthcareProduct of OSANG Healthcare Co., Ltd.: Blood Glucose Test Strips, Registration Certificate No.: China Medical Device Registration No. 20172402227.
 
4. Avanos Medical, Inc.'s 1 product: Enteral Feeding Tubes, Registration Certificate No.: G20192142387.
 
Hereby announced.
 
National Medical Products Administration
 
February 3, 2026